Abstract
Male accessory gland infections (MAGI) have a negative impact on the secretory function of the male accessory glands, hence altering seminal fluid. MAGI can be classified according to the presence/absence of microorganisms in microbial forms, when it is possible to identify the presence of microorganisms, and in inflammatory forms, characterized by leukocytospermia and/or overproduction of reactive oxygen species (ROS). The treatment of choice of the microbial forms of MAGI is based on antibiotic administration, followed by anti-inflammatory drugs and antioxidants. The inflammatory forms, characterized by leukocytospermia and ROS overproduction, are mainly treated with anti-inflammatory drugs followed by antioxidants. Antioxidants may be prescribed both to ameliorate the symptoms of MAGI and to reduce sperm oxidative stress-induced damage that can lead to male infertility.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Agarwal A, Virk G, Ong C, et al. Effect of oxidative stress on male reproduction. World J Mens Health. 2004;32:1–17.
Anothaisintawee T, Attia J, Nickel JC, et al. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA. 2011;305:78–86.
Autilio C, Morelli R, Milardi D, et al. Soluble urokinase-type plasminogen activator receptor as a putative marker of male accessory gland inflammation. Andrology. 2015;3:1054–61.
Balercia G, Buldreghini E, Vignini A, et al. Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril. 2009;91:1785–92.
Balercia G, Regoli F, Armeni T, et al. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. Fertil Steril. 2005;84:662–71.
Bornman MS, du Toit D, Otto B, et al. Seminal carnitine, epididymal function and spermatozoal motility. S Afr Med J. 1989;75:20–1.
Calogero AE, Gullo G, La Vignera S, et al. Myoinositol improves sperm parameters and serum reproductive hormones in patients with idiopathic infertility: a prospective double-blind randomized placebo-controlled study. Andrology. 2015;3:491–5.
Ciftci H, Verit A, Savas M, et al. Effects of N-acetylcysteine on semen parameters and oxidative/antioxidant status. Urology. 2009;74:73–6.
Condorelli RA, Calogero AE, Vicari E, et al. Male accessory gland infection: relevance of serum total testosterone levels. Int J Endocrinol. 2014;2014:915752.
Condorelli RA, La Vignera S, Bellanca S, et al. Myoinositol: does it improve sperm mitochondrial function and sperm motility? Urology. 2012;79:1290–5.
Condorelli RA, La Vignera S, Di Bari F, et al. Effects of myoinositol on sperm mitochondrial function in-vitro. Eur Rev Med Pharmacol Sci. 2011;15:129–34.
Condorelli RA, Vicari E, Calogero AE, et al. Male accessory gland inflammation prevalence in type 2 diabetic patients with symptoms possibly reflecting autonomic neuropathy. Asian J Androl. 2014;16:761–6.
da Silva RF, dos Santos BC, Villela P, et al. The coadministration of N-acetylcysteine ameliorates the effects of arsenic trioxide on the male mouse genital system. Oxid Med Cell Longev. 2016;2016:4257498.
De Rosa M, Boggia B, Amalfi B, et al. Correlation between seminal carnitine and functional spermatozoal characteristics in men with semen dysfunction of various origins. Drugs R D. 2005;6:1–9.
Doba T, Burton GW, Ingold KU. Antioxidant and co-antioxidant activity of vitamin C. The effect of vitamin C, either alone or in the presence of vitamin E or a water-soluble vitamin E analogue, upon the peroxidation of aqueous multilamellar phospholipid liposomes. Biochim Biophys Acta. 1985;835:298–303.
Eskenazi B, Kidd SA, Marks AR, et al. Antioxidant intake is associated with semen quality in healthy men. Hum Reprod. 2005;20:1006–12.
Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A. 1989;86:6377–81.
Gill BC, Shoskes DA. Bacterial prostatitis. Curr Opin Infect Dis. 2016;29:86–91.
Gupta NP, Kumar R. Lycopene therapy in idiopathic male infertility – a preliminary report. Int Urol Nephrol. 2002;34:369–72.
Gvozdjáková A, Kucharská J, Dubravicky J, et al. Coenzyme Q10, α-tocopherol, and oxidative stress could be important metabolic biomarkers of male infertility. Dis Markers. 2015;2015:827941.
Irvine DS. Glutathione as a treatment for male infertility. Rev Reprod. 1996;1:6–12.
Krause WKH. Male accessory gland infection. Andrologia. 2008;40:113–6.
La Vignera S. Male accessory gland infections: anatomical extension of inflammation and severity of symptoms evaluated by an original questionnaire. Andrologia. 2012;44:739–46.
La Vignera S, Condorelli R, D’Agata R, et al. Semen alterations and flow-cytometry evaluation in patients with male accessory gland infections (MAGI). J Endocrinol Invest. 2012;35:219–23.
La Vignera S, Condorelli RA, Vicari E, et al. High frequency of sexual dysfunction in patients with male accessory gland infections. Andrologia. 2012;44:438–46.
La Vignera S, Condorelli RA, Vicari E, et al. Hyperviscosity of semen in patients with male accessory gland infection: direct measurement with quantitative viscosimeter. Andrologia. 2012c;44:556–9.
La Vignera S, Condorelli RA, Vicari E, et al. Microbiological investigation in male infertility: a practical overview. J Med Microbiol. 2014;63:1–14.
La Vignera S, Vicari E, Condorelli RA, et al. Hypertrophic-congestive and fibro-sclerotic ultrasound variants of male accessory gland infection have different sperm output. J Endocrinol Invest. 2011;34:330–5.
La Vignera S, Vicari E, Condorelli RA, et al. Prevalence of human papilloma virus infection in patients with male accessory gland infection. Reprod Biomed Online. 2015;30:385–91.
Lenzi A, Lombardo F, Gandini L, et al. Metabolism and action of L-carnitine: its possible role in sperm tail function. Arch Ital Urol Nefrol Androl. 1992;64:187–96.
Lenzi A, Lombardo F, Sgrò P, et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril. 2003;79:292–300.
Lenzi A, Sgrò P, Salacone P, et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril. 2004;81:1578–84.
Livera G, Rouiller-Fabre V, Durand P, et al. Multiple effects of retinoids on the development of Sertoli, germ, and Leydig cells of fetal and neonatal rat testis in culture. Biol Reprod. 2000;62:1303–14.
Magri V, Montanari E, Škerk V, et al. Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction. Asian J Androl. 2011;13:819–27.
Mancini A, Conte G, Milardi D, et al. Relationship between sperm cell ubiquinone and seminal parameters in subjects with and without varicocele. Andrologia. 1998;30:1–4.
Marconi M, Pilatz A, Wagenlehner F, et al. Impact of infection on the secretory capacity of the male accessory glands. Int Braz J Urol. 2009;35:299–308.
Mishra M, Acharya UR. Protective action of vitamins on the spermatogenesis in lead-treated Swiss mice. J Trace Elem Med Biol. 2004;18:173–8.
Ng CM, Blackman MR, Wang C, et al. The role of carnitine in the male reproductive system. Ann N Y Acad Sci. 2004;1033:177–88.
Perletti G, Marras E, Wagenlehner FM, et al. Antimicrobial therapy for chronic bacterial prostatitis. Cochrane Database Syst Rev. 2013;CD009071.
Rowe P, Comhaire F, Hargreave TB, et al. World Health Organization manual for the standardised investigation and diagnosis of the infertile couple. Cambridge: Cambridge University Press; 1993.
Safarinejad MR. Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men. J Urol. 2009;182:237–48.
Suleiman SA, Ali ME, Zaki ZM, et al. Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl. 1996;17:530–7.
Vicari E. Seminal leukocyte concentration and related specific radical oxygen species production in different categories of patients with male accessory gland infections. Hum Reprod. 1999;14:2025–30.
Vicari E, Calogero AE. Effect of treatment with carnitines in patients with prostato-vesciculo-epididymitis. Hum Reprod. 2001;16:2338–42.
Vicari E, La Vignera S, Calogero AE. Antioxidant treatment with carnitines is effective in infertile patients with prostato-vesciculo-epididymitis and elevated seminal leukocyte concentration after treatment with non-steroidal anti-inflammatory compounds. Fertil Steril. 2002;78:1203–8.
Vicari E, La Vignera S, Garrone F, et al. Terapia ormonale e non ormonale nell’infertilità maschile: indicazione e nuove prospettive. Contraccezione, Fertilità e Sessualità. 2006;33:236–42.
Walczak-Jedrzejowska R, Wolski JK, Slowikowska-Hilczer J. The role of oxidative stress and antioxidants in male fertility. Cent Eur J Urol. 2013;66:60–7.
Wang LL, Huang YH, Yan CY, et al. N-acetylcysteine ameliorates prostatitis via miR-141 regulating Keap1/Nrf2 signaling. Inflammation. 2016;39:938–47.
World Health Organization. WHO laboratory manual for the examination and processing of human semen. 5th ed. Geneva; World Health Organization; 2010.
Yanushpolsky EH, Politch JA, Hill JA, et al. Is leukocytospermia clinically relevant? Fertil Steril. 1996;66:822.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Calogero, A.E., Condorelli, R.A., Vignera, S.L. (2017). Antioxidants in Male Accessory Gland Infection. In: Balercia, G., Gandini, L., Lenzi, A., Lombardo, F. (eds) Antioxidants in Andrology. Trends in Andrology and Sexual Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-41749-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-41749-3_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-41747-9
Online ISBN: 978-3-319-41749-3
eBook Packages: MedicineMedicine (R0)